A serum metabolic fingerprint may predict advanced fibrosis due to NAFLD in a cohort of diabetic patients

被引：0
|
作者：
Forlano, Roberta [1 ]
Mullish, Benjamin H. [1 ]
Blanco, Jesus Miguens [1 ]
Danckert, Nathan [1 ]
Thursz, Mark [1 ]
Manousou, Pinelopi [1 ]
机构：
[1] Imperial Coll London, Dept Metab Digest & Reprod, London, England
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-950
引用
收藏
页码：S540 / S540
页数：1
相关论文
共 50 条
  • [31] NAFLD-HCC Is Associated with Female Sex and Lower Rates of Advanced Fibrosis in a Prospective Cohort of HCC Patients
    Gkouvatsos, Konstantinos
    Myers, Shuna
    Spahr, Laurent
    Giostra, Emiliano
    Bascaron, Marie-Eve
    Frossard, Jean-Louis
    Bouchardy, Christine
    Neyroud, Isabelle
    Negro, Francesco
    Goossens, Nicolas
    HEPATOLOGY, 2018, 68 : 539A - 539A
  • [32] A new score to predict presence of advanced fibrosis in NAFLD and comparison with established scoring systems
    Hagstrom, H.
    Nasr, P.
    Ekstedt, M.
    Hammar, U.
    Hultcrantz, R.
    Stal, P.
    Kechagias, S.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S573 - S574
  • [33] Utility of Transient Elastography and Serum Markers of Fibrosis to Predict Significant and Advanced Fibrosis in Patients with Chronic Hepatitis C
    Samea, Eman Abdel
    Abdel-Razek, Wael
    Ehsan, Nermine
    Salama, Mohsen
    Waked, Imam
    HEPATOLOGY, 2013, 58 : 603A - 603A
  • [34] Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
    Bazick, Jessica
    Donithan, Michele
    Neuschwander-Tetri, Brent A.
    Kleiner, David
    Brunt, Elizabeth M.
    Wilson, Laura
    Doo, Ed
    Lavine, Joel
    Tonascia, James
    Loomba, Rohit
    DIABETES CARE, 2015, 38 (07) : 1347 - 1355
  • [35] Obesity fibrosis score: A new model to predict advanced fibrosis in morbidly obese patients with non-alcoholic fatty liver disease (NAFLD)
    Singh, Tavankit
    Dasarathy, Srinivasan
    Lopez, Rocio
    McCullough, Arthur J.
    HEPATOLOGY, 2015, 62 : 1271A - 1271A
  • [36] Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk
    Delgado, Graciela E.
    Kleber, Marcus E.
    Moissl, Angela P.
    Yazdani, Babak
    Kusnik, Alexander
    Ebert, Matthias P.
    Maerz, Winfried
    Kraemer, Bernhard K.
    Lammert, Alexander
    Teufel, Andreas
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2021, 321 (03): : G252 - G261
  • [37] Reply to: "The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD"
    Ampuero, Javier
    Gallego-Duran, Rocio
    Romero-Gomez, Manuel
    JOURNAL OF HEPATOLOGY, 2021, 74 (04) : 971 - 972
  • [38] PATIENTS WITH METABOLIC SYNDROME AND NAFLD: ASSESSMENT OF OBESITY AND HEART FIBROSIS DEGREE
    Deeva, T.
    Drapkina, O.
    Ivashkin, V.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S735 - S735
  • [39] ASSESSMENT OF NON-INVASIVE TOOLS TO PREDICT ADVANCED FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): DATA FROM A LARGE NATIONAL COHORT
    Savvidou, Savvoula
    Papatheodoridi, Margarita
    Zisimopoulos, Konstantinos
    Koustenis, Kanellos
    Samonakis, Dimitrios N.
    Manolakopoulos, Spilios
    Triantos, Christos U.
    Papatheodoridis, George V.
    Tsoulas, Christos
    Goulis, Ioannis
    HEPATOLOGY, 2019, 70 : 1069A - 1070A
  • [40] SUBOPTIMAL PERFORMANCE OF SHEARWAVE ELASTOGRAPHY (ELASTPQ) FOR PREDICTING ADVANCED FIBROSIS IN A NAFLD ENRICHED COHORT
    Bevan, R.
    Stenberg, B.
    Madhra, M.
    McNeill, A.
    McPherson, S.
    GUT, 2016, 65 : A97 - A97
12345